Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

Vertex Pharmaceuticals and Other Biotech Stocks With Recent Golden Crosses

Golden crosses and death crosses are common signals in technical analysis and refer to the relationship between short-term and long-term moving averages. The golden cross typically is seen as a ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Baidu, BP, Ciena, Chevron, Cree, Exxon, Home Depot, Medtronic, Nvidia, Urban Outfitters and More

Monday's gain and the initial higher open on Tuesday faded into a sell-off as investors dipped back into less risky assets, but Wednesday's major equity indexes were indicated to open ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More

Stocks were indicated to open higher yet again on Tuesday, as June has turned into a complete role reversal from May's "sell in May" theme that was winning. Investors need ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Tower, American Water Works, Bank of America, eBay, FedEx, Lululemon, Morgan Stanley, Vale, Verizon and More

Stocks were indicated up strong by almost 1% on Wednesday morning for the Dow Jones industrial average, S&P 500 and Nasdaq, quite similar to Tuesday's gap-up open. This follows last ...
Read Full Story »

Major Health Care Catalysts Coming by the End of 2018

Companies in the health care sector face great risk and great reward every time they make an announcement. Drug candidates passing clinical trials, gaining regulatory approval or being canceled can ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AECOM, CyberArk, Dillard’s, Hasbro, Mattel, Newell, Papa John’s, Shopify, Snap, Tesla and More

Stocks were indicated to open marginally lower on Wednesday after China matched tariffs in the ongoing trade war. Investors have seen a strong earnings season, with more than 70% of ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AT&T, Comcast, Disney, Hess, Netflix, Petrobras, Sirius XM, Texas Instruments, Verizon and More

Stocks were indicated handily lower on Wednesday, both in the United States and abroad, based on new trade war fears after President Trump signaled a higher $200 billion targeted ...
Read Full Story »

4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018

While large cap pharmaceutical stocks have had a very solid year despite the rumbling by the administration over drug pricing, many smaller specialty pharmaceuticals have lagged. Despite that underperformance, some ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical, Unilever and More

The market finished higher Friday, finally posting some gains after struggling most of the week with concerns over trade tariffs and the potential for a trade war. The futures are ...
Read Full Story »

Stifel Has 5 Specialty Pharmaceutical 2018 Buys With Massive Upside Potential

Despite a roaring market in 2017, in which the S&P 500 was up almost 20% on the year, the specialty pharmaceutical group and biotechs severely underperformed. In addition, the performance ...
Read Full Story »

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

After a horrible 2015 and 2016, the biotechnology industry finally came back to life in 2017, shrugging off many of the issues that have clouded the waters, especially during the ...
Read Full Story »

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

With the market looking ready to continue running to all-time highs despite yesterday's selling, many pundits feel this late stage part of the rally is more people trying to get ...
Read Full Story »

ImmunoGen Riding High on Jazz Pharma Deal

ImmunoGen Inc. (NASDAQ: IMGN) announced this week that it has decided to partner with Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate ...
Read Full Story »

ImmunoGen and Jazz Enter Into Global Collaboration

ImmunoGen Inc. (NASDAQ: IMGN) has decided to partner with Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate (ADC) programs, as well as ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Applied Materials, Cerner, Cisco, J&J, Level 3, Salesforce and Many More

Stocks were indicated to open marginally higher on Monday despite a global hack spreading. The major market indexes are all within striking distance of all-time highs. It is also important ...
Read Full Story »